Pelayo Jerald, Lo Kevin Bryan, Sultan Sahar, Quintero Eduardo, Peterson Eric, Salacupa Grace, Zanoria Martin Angelo, Guarin Geneva, Helfman Beth, Sanon Julien, Mathew Roy, Yazdanyar Ali, Navarro Victor, Pressman Gregg, Rangaswami Janani
Department of Medicine, Einstein Medical Center, Philadelphia, PA, United States.
Department of Emergency and Hospital Medicine, Lehigh Valley Hospital-Cedar Crest, Allentown, PA, United States.
Int J Cardiol Heart Vasc. 2022 Aug 11;42:101094. doi: 10.1016/j.ijcha.2022.101094. eCollection 2022 Oct.
Hepatorenal syndrome (HRS), a form of kidney dysfunction frequent in cirrhotic patients, is characterized by low filling pressures and impaired kidney perfusion due to peripheral vasodilation and reduced effective circulatory volume. Cardiorenal syndrome (CRS), driven by renal venous hypertension and elevated filling pressures, is a separate cause of kidney dysfunction in cirrhotic patients. The two entities, however, have similar clinical phenotypes. To date, limited invasive hemodynamic data are available to help distinguish the primary forces behind worsened kidney function in cirrhotic patients.
Our aim was to analyze invasive hemodynamic profiles and kidney outcomes in patients with cirrhosis who met criteria for HRS.
We conducted a single center retrospective study among cirrhotic patients with worsening kidney function admitted for liver transplant evaluation between 2010 and 2020. All met accepted criteria for HRS and underwent concurrent right heart catheterization (RHC).
127 subjects were included. 79 had right atrial pressure >10 mmHg, 79 had wedge pressure >15 mmHg, and 68 had both. All patients with elevated wedge pressure were switched from volume loading to diuretics resulting in significant reductions between admission and post diuresis creatinine values (2.0 [IQR 1.5-2.8] vs 1.5 [IQR 1.2-2.2]; p = 0.003).
62% of patients diagnosed with HRS by clinical criteria have elevated filling pressures. Improvement of renal function after diuresis suggests the presence of CRS physiology in these patients. Invasive hemodynamic data profiling can lead to meaningful change in management of cirrhotic patients with worsened kidney function, guiding appropriate therapies based on filling pressures.
肝肾综合征(HRS)是肝硬化患者常见的一种肾功能障碍形式,其特征是由于外周血管扩张和有效循环血容量减少导致充盈压降低和肾脏灌注受损。心肾综合征(CRS)由肾静脉高压和充盈压升高引起,是肝硬化患者肾功能障碍的另一个原因。然而,这两种情况具有相似的临床表型。迄今为止,可用的有创血流动力学数据有限,难以帮助区分肝硬化患者肾功能恶化背后的主要因素。
我们的目的是分析符合HRS标准的肝硬化患者的有创血流动力学特征和肾脏预后。
我们对2010年至2020年间因肝移植评估而入院的肾功能恶化的肝硬化患者进行了一项单中心回顾性研究。所有患者均符合公认的HRS标准,并同时接受了右心导管检查(RHC)。
纳入127名受试者。79人右心房压>10mmHg,79人楔压>15mmHg,68人两者均升高。所有楔压升高的患者均从容量负荷治疗改为利尿剂治疗,导致入院时和利尿后肌酐值显著降低(2.0[四分位间距1.5 - 2.8] vs 1.5[四分位间距1.2 - 2.2];p = 0.003)。
根据临床标准诊断为HRS的患者中,62%的患者充盈压升高。利尿后肾功能改善表明这些患者存在CRS生理状态。有创血流动力学数据剖析可导致肾功能恶化的肝硬化患者管理发生有意义的变化,根据充盈压指导适当的治疗。